Nicole Wiggins, NP

52% fewer Medicare Part D claims than the average family nurse practitioner in 2024

627 Medicare Part D claims for 164 beneficiaries, against an average of 1,305 among the 140,557 providers of this specialty who prescribed in Part D. Brand-name drugs were 47% of claims.

Most prescribed

1. Albuterol Sulfate Hfa118 claims
2. Trelegy Ellipta104 claims
3. Montelukast Sodium39 claims
4. Breo Ellipta35 claims
5. Fluticasone-Salmeterol28 claims
6. Fluticasone Propionate26 claims

Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.

The practice group's MIPS final score for 2023 (Medicare payment program): 80.3 of 100

The Merit-based Incentive Payment System score is reported for the practice group, not for one clinician alone. Four categories are weighted into the final score; the average among 454,083 clinicians with a measured score was 83.5.

Source: CMS Quality Payment Program, MIPS performance year 2023, group reporting; category weights for 2023 (qpp.cms.gov).

Industry payments in 2024: $105.18

5 payments; by number, the most common kind was food and beverage; the largest payer was Boehringer Ingelheim Pharmaceuticals, Inc. The 99,489 providers of this specialty with any payment received $650.95 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.

Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.